On May 10, 2021, Ms. Cui Shan resigned as an independent director and the chairperson of the Audit Committee of Addentax Group Corp. On May 10, 2021, the Board of Directors (the “Board”) of the company appointed Mr. Alex P. Hamilton (“Mr. Hamilton”) as an independent director effective on the date of the Company’s completion of its public offering and the listing of its ordinary shares on a national securities exchange, whichever is the later (the “Effective Date”). Mr. Hamilton will serve as the chairman of the audit committee and the “audit committee financial expert” as defined by in Item 407(d)(5) of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended. Mr. Alex P. Hamilton, age 47, has been the Chief Financial Officer of CBD Biotech Inc. since November 2018, and has also served as Director of CBD Biotech Inc. since April 2019.